Answer Genomics raises $500K in pre-Series A round from IPV

Personalized and data driven wellness platform Answer Genomics has raised $500K in a pre-series A Round from Inflection Point Ventures. 

The proceeds will be used in sales and marketing efforts and expanding the talent pool through strategic hiring initiatives, the firm said in a press release. 

Led by Rahul Ranganathan, Answer Genomics combines genomic, physiological, and physical parameters to provide a picture of present and future health. It predicts the occurrence, spread, and treatment of lifestyle and clinical disorders by assaying genetic makers using their proprietary genomic and machine.

According to the company, it is collecting samples from people with their consent to create a database of genetic information. It takes a small amount of blood and analyze more than 5 million data points from it looking at various parameters including genes, medical history, microbiome, and lifestyle to give advice on how to be healthy now and in the future. 

The company has also filed for 2 patents and holds publications papers in important peer reviewed journals. 

Earlier to this round, the firm had raised an undisclosed amount in 2021 from India Accelerator. 

As per data compiled by TheKredible, Inflection Point Ventures led the investment landscape in the third quarter of 2023 or Q3 with 13 deals. Check the full report here.